気管支喘息治療のストラテジー ―治療の実際―

出版社： 先端医学社
著者：
発行日： 2001-12-25
分野： 臨床医学：内科  >  呼吸器一般
ISBN： 9784884070465
電子書籍版： 2001-12-25 （第1版第1刷）
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,090 円(税込)

購入する

商品紹介

疾患を多方面からのアプローチでとらえ、日常臨床で必要な薬剤の効果的かつ適切な使用法等、治療戦略に不可欠な情報を提示
ガイドラインにもとづいた気管支喘息治療の原則と病態別治療の留意点を簡潔に解説。さらに主となる治療薬の特徴と適応の基本を収載し、実践に役立つ情報をコンパクトに把握できる一冊。

目次

  • 表紙
  • 序文
  • 執筆者一覧
  • 目次
  • PART 1/合併症を伴った気管支喘息の治療の実際
  • COPDを合併した気管支喘息の治療
  • 気道感染を合併した気管支喘息の治療
  • 鼻炎・副鼻腔炎を合併した気管支喘息の治療
  • PART 2/気管支喘息の吸入療法実施の原則とその正しい使い方の指導法
  • 吸入薬の特徴と患者指導のポイント
  • 定量吸入器(MDI)の特徴と使用法に対する患者指導
  • 各種ジェット式ネブライザーの特性と正しい使用法の指導
  • 吸入療法におけるコンプライアンスの現状と課題
  • PART 3/気管支喘息の治療
  • 気管支喘息でのステップアップ・ステップダウン
  • 気管支喘息治療でのearly interventionの意義
  • 急性管理の観点からみた気管支喘息
  • 長期管理の観点からみた気管支喘息
  • 小児気管支喘息の急性管理と長期管理
  • PART 4/おもな気管支喘息治療薬とその適応
  • 吸入ステロイド薬の特徴と適応の基本
  • β2刺激薬pMDIおよび貼付剤の特徴と適応の基本
  • 徐放性テオフィリン薬の特徴と適応の基本
  • 抗アレルギー薬の特徴と適応の基本
  • ロイコトリエン拮抗薬の特徴と適応の基本
  • TXA2拮抗薬の特徴と適応の基本
  • 索引
  • 和文索引
  • 欧文索引
  • 薬剤一覧
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

PART 1/合併症を伴った気管支喘息の治療の実際

P.12 掲載の参考文献
1) Callahan CM, Dittus RS, Katz BP:Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 114:216-223, 1991
PubMed
2) Boulet LP, Becker A, Berube D et al:Summary of recommendation from the Canadian Asthma Consensus Report 1999. CMAJ 161:S1-S12, 1999
PubMed
3) British Thoracic Society:The British guidelines on asthma management reviewed and position statement-introduction. Thorax:52:S1-S21, 1997
 
P.17 掲載の参考文献
1) Nicholson KG, Kent J, Ireland DC :Respiratory viruses and exacerbations of asthma in adults. BMJ 307:982-986, 1993
PubMed
2) Corne JM, Holgate ST:Mechanisms of virus induced exacerbations of asthma. Thorax 52:380-389, 1997
PubMed
3) Folkerts G, Busse WW, Nijkamp FP et al:Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 157:1708-1720, 1998
PubMed
4) Johnston SL, Pattemore PK, Sanderson G et al:Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310:1225-1229, 1995
PubMed
5) Vignola AM, Campbell AM, Chanez P et al:HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 148:689-694, 1993
PubMed
6) Hahn DL, Dodge RW, Golubjatnikov R:Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266:225-230, 1991
PubMed
7) Miyashita N, Kubota Y, Nakajima M et al:Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 80:405-409, 1998
PubMed
8) Hahn DL, Bukstein D, Luskin A et al:Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 80:45-49, 1998
PubMed
9) Oehling AK:Bacterial infection as an important triggering factor in bronchial asthma. J Invest Allergol Clin Immunol 9:6-13, 1999
 
10) Toogood JH:Side effects of inhaled corticosteroids. J Allergy Clin Immunol 102:705-713, 1998
PubMed
11) Brogden RN, Heel RC, Speight TM et al:Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 28:99-126, 1984
PubMed
12) 渡辺好明, 田中斉, 小川友子:プロピオン酸ベクロメタゾン吸入療法の喘息発作時細菌気道感染への影響. アレルギー46:1132-1135, 1997
 
13) 小林信之, 工藤宏一郎:吸入ステロイドの肺結核症など呼吸器感染症に及ぼす影響. アレルギー科11:25-31, 2001
 
14) 工藤宏一郎:難治性喘息のエリスロマイシンによる治療例. 治療学 27:101-104, 1993
Medical*Online
P.23 掲載の参考文献
1) 石戸谷淳一, 工藤宏一郎:気管支喘息における慢性副鼻腔炎. 日胸疾誌 55:S186-S192, 1996
 
2) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン, 牧野荘平監修, 協和企画通信, 東京, 1998, p137
 
3) Adinoff AD, Irvin CG:Upper respiratory tract disease and asthma. Semin Respir Med 8. 308-314, 1987
 
4) de Benedictis FM, Bush A:Rhinosinusitis and asthma:epiphenomenon or causal association? Chest 115:550-556, 1999
PubMed
5) 鼻アレルギー診療ガイドライン作成委員会:鼻アレルギー診療ガイドライン-通年性鼻炎と花粉症- (改訂第3版), ライフサイエンス・メディカ, 東京, 1999, pp24-38
 
6) 伊藤幸治:「アレルギー疾患に対する治療ワクチン」に対する世界保健機構 (WHO) の見解. アレルギー 47:749-794, 1998
 
7) Gani F, Pozzi E, Crivellaro MA et al:The role of patient training in the management of seasonal rhinitis and asthma:clinical implications. Allergy 56:65-68, 2001
PubMed
8) Corren J, Adinoff AD, Buchmeier AD et al:Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 90:250-256, 1992
PubMed
9) 間島雄一:鼻茸・副鼻腔炎のステロイド治療. JOHNS 14:1423-1428, 1998
 
10) 洲崎春海:マクロライドと副鼻腔炎. 日胸疾誌 55:S78-S87, 1996
 
11) English GM:Nasal polypectomy and sinus surgery in patients with asthma and aspirin idiosyncrasy. Laryngoscope 96:374-380, 1986
PubMed
12) 1keda K, Tanno N, Tamura G et al:Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol 108:355-359, 1999
 
13) Dunlop G, Scadding GK, Lund VJ:The effect of endoscopic sinus surgery on asthma:management of patients with chronic rhinosinusitis, nasal polyposis, and asthma. Am J Rhinol 13:261-265, 1999
PubMed
14) Senior BA, Kennedy DW, Tanabodee J et al:Long-term impact of functional endoscopic sinus surgery on asthma. Otolaryngol Head Neck Surg 121:66-68, 1999
PubMed
15) 寺田満和:気管支喘息難治化因子の多重ロジスティック回帰分析を用いた統計学的検討. アレルギー 45:461-471, 1996
Medical*Online

PART 2/気管支喘息の吸入療法実施の原則とその正しい使い方の指導法

P.32 掲載の参考文献
1) Bousquet J, Chanez P, Lacoste JY et al:Asthma:a disease remodeling the airway. Allergy 47:3-11, 1992
PubMed
2) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン1998 改訂版. 牧野荘平ほか編, 協和企画通信, 東京, 1998, pp66-94
 
3) Jeffery PK, Wardlaw AJ, Nelson FC et al:Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 140:1745-1753, 1989
PubMed
4) Chetta A, Foresi A, Del Donno M et al:Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 153:910-917, 1996
PubMed
5) Laitinen LA, Laitinen A, Haahtela T:A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma:a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 90:32-42, 1992
 
6) Trigg CJ, Manolitsas ND, Wang J et al:Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 150:17-22, 1994
PubMed
7) Laitinen A, Altraja A, Kampe M et al:Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 156:951-958, 1997
PubMed
8) Haahtela T, Jarvinen M, Kava T et al:Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325:388-392, 1991
PubMed
9) Haahtela T, Jarvinen M, Kava T et al:Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700-705, 1994
 
10) Selroos O, Pietinalho A, Lofroos AB et al:Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108:1228-1234, 1995
PubMed
11) 宮本昭正, 瀧島任, 牧野荘平ほか:Fluticasone propinate(SN411)吸入用散剤の臨床的検討(第4報)-気管支喘息に対するbeclomethasone dopropinate inhalerとの比較-. 臨床医薬13:1609-1633, 1997
 
12) Pauwels RA, Lofdahl CG, Postma DS et al:Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) Intemational Study Group. N Engl J Med 337:1405-1411, 1997
 
13) Donahue JG, Weiss ST, Livingston JM et al:Inhaled steroids and the risk of hospitalization for asthma. JAMA 277:887-891, 1997
PubMed
14) Rebuck AS, Chapman KR, Abboud R et al:Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 82:59-64, 1987
PubMed
15) Bryant DH:Nebulized ipratropium bromide in the treatment of acute asthma. Chest 88:24-29, 1985
PubMed
P.39 掲載の参考文献
1) 藤村直樹:ハンドネブライザーからドライパウダー吸入へ-これからの吸入ステロイド治療. 吸入ステロイド・ハンドブック, 足立満編, 南江堂, 東京, 1998, pp101-110
 
2) 藤村直樹:吸入療法におけるディヴァイスの重要性. アレルギー・免疫 6:914-918, 1999
 
3) 藤村直樹:薬剤送達システム. 知って得する吸入療法のこつ, 足立満, 永倉俊和編, メディカルレビュー社, 東京, 2001, pp 129-137
 
4) 藤村直樹:フロン廃止後の吸入療法の展望. info Allergy 2:5,1999
 
5) 藤村直樹:ドライパウダー吸入-特徴と展望-. 呼吸15:502-508, 1996
 
P.44 掲載の参考文献
1) 高木健三, 田中斉:エアゾル吸入の原理. 気管支喘息における吸入療法ハンドブック, 宮本昭正編, メディカルレビュー社, 東京, 1992, pp2-5
 
2) 黒坂文武:5機種の電動ネブライザーのサルブタモール吸入による気管支拡張効果の比較. 日本小児科学会雑誌103:447-450, 1999
 
3) 日本アレルギー学会:小児における吸入機器とその使い方. 小児気管支喘息治療・管理ガイドライン2000, 古庄巻史, 西間三馨編, 協和企画, 東京, 2000, pp49-53
 
P.49 掲載の参考文献
1) 小田島安平, 飯倉洋治:気管支喘息の治療の実際-小児科. 臨床と研究76:2085-2100, 1999
 
2) 廣田常夫:小児気管支喘息における吸入療法のコンプライアンスについて. アレルギー 49:225, 2000
Medical*Online
3) 松本一彦, 西川三喜男, 橋本久邦ほか:吸入ステロイド治療における薬剤師による吸入指導の意義. アレルギー 47:404-412, 1998
Medical*Online
4) 宮川武彦:吸入ステロイド薬の使用状況に関する検討. アレルギー 49:986, 2000
Medical*Online
5) 鈴木知子, 長谷川隆志, 真島一郎ほか:気管支喘息に対するベクロメタゾンエアロゾールのコンプライアンスの実態調査. アレルギー 49:989, 2000
 
6) 國分二三男, 鈴木一, 佐野靖之ほか:喘息テレメディスンシステムのハイリスクグループに対する有効性の検討. アレルギー 48:700-712, 1999
 
7) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン, 協和企画通信, 東京, 1998, pp65-107
 
8) 菅野智, 駒瀬祐子, 柳川忠二ほか:ディスクヘラー導入後の患者の意識調査およびコンプライアンスの検討. 喘息 13:108-113, 2000
 
9) 石原享介, 羽白高, 藤井宏:難治性喘息におけるステロイド吸入療法の有用性と限界. アレルギー 49:862, 2000
Medical*Online
10) 大川原弘美, 湯地博美, 岩元美幸ほか:他科ごとではない喘息疾患事例にみる喘息患者の看護コンプライアンスの低い患者への日常生活指導個別指導を試みて. 看護技術 46:516-520, 2000
 
11) 小原央生, 高橋孝輔, 高木康之ほか:BDPからFPへ変更した気管支喘息患者の満足度およびコンプライアンスについての検討. アレルギー 49:235, 2000
Medical*Online
12) 加藤聡之, 岩田勝, 吉田憲生ほか:プロピオン酸フルチカゾン(FP)400μg1日1回吸入から200μg1日2回吸入に変更した気管支喘息患者の検討. アレルギー 49:988, 2000
Medical*Online
13) Suissa S, Ernst P, Benayoun S et al:Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343:332-336, 2000
PubMed

PART 3/気管支喘息の治療

P.59 掲載の参考文献
1) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画通信, 東京, 1998
 
2) van der Molen T, Meyboom-de Jong B, Mulder HH et al:Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am J Respir Crit Care Med 158:121-125, 1998
PubMed
3) Gershman NH, Wong HH, Liu JT et al:Low-and high-dose fluticasone propionate in asthma;effects during and after treatment. Eur Respir J 15:11-18, 2000
PubMed
4) Wilson AM, Lipworth BJ:Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 108:269-275, 2000
PubMed
5) Tukiainen H, Taivainen A, Majander R et al:Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. Respir Med 94:678-683, 2000
PubMed
6) Kohno Y, Minoguchi K, Adachi M et al:Step down therapy is more effective to gain prompt control of asthma and reduces the maintenance dose inhaled steroids than step up therapy in moderate asthma. J Allergy Clin Immunol 105:264s, 2000
 
7) Barnes PJ, Pedersen S:Efficacy and safety of inhaled corticosteroidsin asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 148:S1-S26, 1993
 
P.72 掲載の参考文献
1) The British Guidlines on Asthma Management 1995 Review and Position Statement. Thorax:52(suppl. 1) :S1-S21, 1997
 
2) Haahtela T, Laitinen LA:Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy 26(suppl) :1-24, 1996
 
3) Expert Panel Report 2. Guidlines for the diagnosis and management of asthma. NIH Publication No. 97-4051, July 1997
 
4) Holt PG, Clough JB, Holt BJ et al:Genetic risk for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 22:1093-1099, 1992
PubMed
5) Jones AC, Miles EA, Warner JO et al:Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 7:109-116, 1996
PubMed
6) Warner JA, Jones CA, Jones AC et al:Immune responses during pregnancy and the development of allergic disease. Pediatr Allergy Immunol 8(suppl) :5-10, 1997
 
7) Kjellman NI:Effect of parental smoking on IgE levels in children Lancet 1:993-994, 1981
PubMed
8) Arshad SH, Matthews S, Gant C et al:Effect of allergen avoidance on development of allergic disorders in infancy. Lancet 339:1493-1497, 1992
PubMed
9) Sporik R, Holgate ST, Platts-Mills TA et al:Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 323:502-507, 1990
PubMed
10) Shirakawa T, Enomoto T, Shimazu S et al:The inverse association between tuberculin responses and atopic disorder. Science 275:77-79, 1997
PubMed
11) Martinez F D, Wright A L, Taussig L M et al:Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332:133-138, 1995
 
12) 0swald H, Phelan PD, Lanigan A et al:Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 23:14-20, 1997
 
13) Blair H:Natural history of childhood asthma. 20-year follow-up. Arch Dis Child 52:613-619, 1977
PubMed
14) Martin A J, Landau L I, Phelan P D:Predicting the course of asthma in children. Aust Paediatr J 18:84-87, 1982
PubMed
15) Ninan T K, Russell G:Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 67:703-705, 1992
PubMed
16) Johnson P R, Black J L, Carlin S et al:The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture:the effect of beclomethasone. Am J Respir Crit Care 162:2145-2151, 2000
 
17) Laitinen A, Altraja A, Kampe M et al:Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 156:951-958, 1997
PubMed
18) Laitinen L A, Altraja A, Karjalainen E M et al:Early interventions in asthma with inhaled corticosteroids. J Allergy Clin Immunol 105:S582-S585, 2000
PubMed
19) Koig P:The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. J Allergy Clin Immunol 105:S575-S581, 2000
 
20) Kimata H, Yoshida A, Ishioka C et al:Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production in human B cells in vitro. Clin Exp lmmunol 84:389-399, 1992
 
21) Tinkelman D G, Reed C E, Nelson H S et al:Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 92:64-77, 1993
PubMed
22) Doull I J, Freezer N J, Holgate S T:Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 151:1715-1719, 1995
PubMed
23) Zieg G, Lack G, Harbeck R J et al:In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol 94:222-230, 1994
PubMed
24) Hiratsuka S, Yoshida A, Ishioka C et al:Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis. J Allergy Clin Immunol 98:107-113, 1996
PubMed
P.80 掲載の参考文献
1) 厚生省免疫・アレルギー研究班:急性憎悪(発作)に対する対応(成人). 喘息予防・管理ガイドライン, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画通信, 東京, 1998, pp84-95
 
2) Johnson S, Kjartansson G, Gislason D et al:Comparison of the oral and intravenous routes for treating asthma with methylpredonisolone and theophyline. Chest 94:723-726, 1998
 
3) Meduri GU, Cook TR, Turner RE et al:Noninvasive positive pressure ventilation in status asthmaticus. Chest 110:767-774, 1996
PubMed
4) Darioli R, Perret C:Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 129:385-387, 1984
PubMed
5) Kamei T, Fujita J, Okada H et al:Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with InspirEase to relieve acute asthma attack. J Asthma 36:67-75, 1999
PubMed
P.88 掲載の参考文献
1) National Asthma Education Program, Expert Panel Report:Guidelines for the diagnosis and management of asthma, US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1991 (大久保隆男, 泉孝英監訳:気管支喘息の診断と治療,-NIHガイドライン, 医学書院, 東京, 1993)
 
2) NHLBI/WHO workshop report (C.Lenfant et al):Global initiative for asthma, Global strategy for asthma management and prevention, NHLBI/WHO workshop report, March 1993, National Institutes of Health, National Heart, Lung, and Blood Institute, Publication Number 95-3659, 1995 (日本語訳, 牧野荘平監修:喘息管理の国際指針, 喘息管理・予防のグローバルストラテジー-NHLBI/WHOワークショップレポート, 国際医学出版, 東京, 1995)
 
3) Strachan DP, Butland BK, Anderson HR:Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 312:1195-1199, 1996
 
4) Jenkins MA, Hopper JL, Bowes G et al:Factors in childhood as predictors of asthma in adult life. BMJ 309:90-93, 1994
PubMed
5) Sears MR:Growing up with asthma. BMJ 309:72-73, 1994
PubMed
6) Rackemann FM, Edwards MC:Is intrinsic asthma a reversible disease? Allergy 29:528-536, 1958
PubMed
7) Bronnimann S, Burrows B:A prospective study of the natural history of asthma. Remission and relapse rates. Chest 90:480-484, 1986
 
8) Marquette CH, Saulnier F, Leroy O et al:Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 146:76-81, 1992
PubMed
9) Silverstein MD, Reed CE, O'Connell EJ et al:Long-term survival of a cohort of community residents with asthma. N Engl J Med 331:1537-1541, 1994
PubMed
10) Ulrik CS:Outcome of asthma:longitudinal changes in lung function. Eur Respir J 13:904-918, 1999
PubMed
11) Radford PJ, Hopp RJ, Biven RE et al:Longitudinal changes in bronchial hyperresponsiveness in asthmatic and previously asthmatic children. Chest 101:624-629, 1992
PubMed
12) Roorda RJ, Gerritsen J, van Aalderen WMC et al:Follow-up of asthma from childhood to adulthood:influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 93:575-584, 1994
 
13) Jansen DF, Timens W, Kraan J et al:(A) symptomatic bronchial hyper-responsiveness and asthma. Respir Med 91:121-134, 1997
PubMed
14) Pedersen S:Can steroids cause asthma to remit? Am J Respir Crit Care Med 153:S31-S32, 1996
PubMed
15) Vathenen AS, Knox AI, Wisniewski A et al:Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 143:1317-1321, 1991
 
16) Juniper EF, Kline PA, Vanzieleghem MA et al:Reduction of budesonide after a year of increased use:a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 87:483-489, 1991
PubMed
17) Haahtela T, Jarvinen M, Kava T et al:Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700-705, 1994
 
18) Childhood Asthma Management Program Research Group (Szefler S, Weiss S, Tonascia J et al):Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343:1054-1063, 2000
PubMed
19) Agertoft L, Pedersen S:Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343:1064-1069, 2000
PubMed
20) Dennis SM, Sharp SJ, Vickers MR et al:Regular inhaled salbutamol and asthma control:the TRUST randomised trial. Lancet 355:1675-1679, 2000
PubMed
21) Laviolette M, Malmstrom K, Lu S et al:Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 160:1862-1868, 1999
PubMed
22) Ignacio-Garcia JM, Gonzalez-Santos P:Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med 151:353-359, 1995
PubMed
23) Turner MO, Taylor D, Bennett R et al:A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med 157:540-546, 1998
 
24) Grampian Asthma Study of Integrated Care (GRASSIC) :Effectiveness of routine self monitoring of peak flow in patients with asthma. BMJ 308:564-567, 1994
PubMed
P.95 掲載の参考文献
1) 日本小児アレルギー学会:小児気管支喘息治療・管理ガイドライン 2000, 古庄巻史, 西間三馨監修, 協和企画, 東京, 2000, pp29-48, pp113-123
 
2) 岩崎栄作:乳幼児・小児のテオフィリン使用. アレルギー・免疫 6:1239-1242, 1999
 
3) 小幡俊彦, 松田秀一, 赤澤晃ほか:小児気管支喘息. アレルギーの臨床 11:733-738, 1991
 

PART 4/おもな気管支喘息治療薬とその適応

P.104 掲載の参考文献
1) 石原享介:吸入ステロイド薬の位置付け. 気管支喘息, 中川武正, 秋山一男編集, 南江堂, 東京, 1999, pp60-68
 
2) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン1998 改訂版, 協和企画, 2000, 東京, p67
 
3) 中川武正:吸入ステロイド薬の使い方. 呼吸と循環 44:65-69, 1996
 
4) Barnes PJ:Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875, 1995
PubMed
5) 石田明, 中川武正:最近の抗アレルギー薬. 呼吸と循環, 2001 (印刷中)
 
P.110 掲載の参考文献
1) Ahlquist RP:A study of adrenotropic receptors. Am J Physiol 153:586-600, 1948
PubMed
2) Lands AM, Arnold A, McAuliff JP et al:Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597- 598, 1967
 
3) Harold SN:β-adrenergic agonists. Asthma, ed by Barnes PJ, GrunsteinMM, LeffAR et al, Lippincott-Raven Publishers, Philadelphia, 1997, pp1507-1521
 
4) Sears MR, Taylor DR, Print CG et al. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 336:1391-1396, 1990
 
5) Burgess CD, Beasley R, Crane J et al:Adverse effects of β 2-agonists. β 2-agonists in asthma treatment, ed by Pauwels R, O'Byrne PM, Marcel Dekker Inc, New York, 1997, pp257-282
 
6) Drazen JM, Israel E, Boushey HA et al:Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med 335:841-847, 1996
PubMed
7) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン改定第1版, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画, 東京, 2000
 
8) 田村弦, 山内広平, 本間正明ほか:成人気管支喘息に対するツロブテロール経皮吸収型製剤(HN-078)の長期投与. 臨床医薬 11:1067-1080, 1995
Medical*Online
P.118 掲載の参考文献
1) Nakano J, Nakazawa K, Ohta K et al:Prevalence of bronchial asthma in adults increases in Japan-epidemilogic studies of asthma in fujieda city in 1985 and 1998-. Am J Respir Critical Care Med 161:A798, 2000
 
2) 中野純一, 大田健. 喘息治療におけるテオフィリン徐放製剤の使い方. MEDICAMENT NEWS, ライフ・サイエンス, 東京, 1996, pp8-10
 
3) Kidney J, Dominguez M, Taylor PM et al:Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 151:1907-1914, 1995
PubMed
4) Sullivan P, Bekir S, Jaffar Z et al:Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343:1006-1008, 1994
PubMed
5) Ohta K, Sawamoto S, Nakajima M et al:The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 26:10-15, 1996
PubMed
6) Nakano J, Ohta K, Nakajima Y et al:Theophylline has an anti-inflammatory effect Via inhibition of the release of eosinophil cationic protein (ECP) in the management of asthma. Am J Respir Critical Care Med 155:A660, 1997
 
7) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン 1998, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画, 東京, 1998
 
8) 中野純一, 大田健:この薬のこの副作用(第二版)ニューキノロン系抗菌薬とテオフィリン代謝異常, 医歯薬出版, 東京, 2000, pp262-265
 
P.133 掲載の参考文献
1) 冨岡玖夫, 鏡味勝:気管支喘息におけるアラキドン酸代謝産物の役割. 総説プロスタグランジン2, 現代医療編集委員会編集, 現代医療社, 東京, 1994, pp105-123
 
P.137 掲載の参考文献
1) Kleeberger SR, Freed AN:Prostanoids. Asthma and rhinitis, ed by Busse WW, Holgate ST, Blackwell Scientific Publications, Inc., Cambridge, MA, USA, 1995, pp825-837
 
2) Iwamoto I, Ra C, Sato T et al:Thromboxane A2 production in alergen-induced immediate and late asthmatic responses. Its possible role in inducing the late response. J Asthma 25:117-124, 1988
 
3) Kleeberger SR, Kolbe J, Adkinson NF Jr et al:Thromboxane contributes to the immediate antigenic response of canine peripheral airways. J Appl Physiol 62:1589-1595, 1987
 
4) Lotvall J, Elwood W, Tokuyama K et al:A thromboxane mimetic, U-46619, produces plasma exudation in airways of the guinea pig. J Appl Physiol 72:2415-2419, 1992
PubMed
5) Chung KF, Aizawa H, Becker AB et al:Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor(OKY-046)in allergic dogs. Am Rev Respir Dis 134:258-261, 1986
PubMed
6) Jones GL, Saroea HG, Watson RM et al:Effect of an inhaled thromboxane mimetic(U46619)on airway function in human subjects. Am Rev Respir Dis 145:1270-1274, 1992
PubMed
7) Saroea HG, Inman MD, O'Byrne PM:U46619-induced bronchoconstriction in asthmatic subjects is mediated by acetylcholine release. Am J Respir Crit Care Med 151:321-324, 1995
PubMed
8) Chung KF, Evans TW, Graf PD et al:Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U46619. Eur J Pharmacol 117:373-375, 1985
PubMed
9) Noveral JP, Grunstein MM:Role and mechanism of thromboxane induced proliferation of cultured airway smooth muscle cells. Am J Physiol 263:L555-L561, 1992
PubMed
10) Hoshino M, Sim J, Shimizu K et al:Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma. J Allergy Clin Immunol 103:1054-1061, 1999
PubMed
11) Fujimura M, Sasaki F, Nakatsumi Y et al:Effects of a thromboxane synthetase inhibitor(OKY-046)and a lipoxygenase inhibitor(AA-861)on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 41:955-959, 1986
 
12) Fujimura M, Kamio Y, Kasahara K et al:Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 8:1499-1505, 1995
PubMed
13) Fujimura M, Sakamoto S, Saito M et al:Effect of a thromboxane A2 receptor antagonist(AA-2414)on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 87:23-27, 1991
PubMed

書評

最近チェックした商品履歴

Loading...